As a major component of cell membrane lipids, Arachidonic acid (AA), being a major
component of the cell membrane lipid content, is mainly metabolized by three kinds of …

The discovery in 2009 of the M-type phospholipase A2 receptor (PLA2R) as the primary
target in membranous nephropathy (MN) greatly advanced basic and clinical research …

Primary membranous nephropathy (pMN) is an auto-immune disease characterized by auto-
antibodies targeting podocyte antigens resulting in activation of complement and damage to …

Autoantibodies against phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type 1
domain-containing 7A (THSD7A) are emerging as biomarkers to classify membranous …

The discovery of anti-podocyte antibodies in primary membranous nephropathy (MN) has
revolutionized our approach toward the diagnosis and treatment of this disease. Evaluation …

Background: This study aimed to evaluate clinical features and prognosis and therapy
option of patients with different risk ranks based on antibody against the M-type …

Membranous nephropathy (MN) is the main cause of adult nephrotic syndrome (NS). The
pathogenesis of MN is complex and involves subepithelial immune complex deposition …

Primary membranous nephropathy (pMN) is an autoimmune kidney disease and a common
cause of nephrotic syndrome in adults. Rituximab is becoming a first line therapy for patients …

Introduction Personalized treatment for patients with membranous nephropathy requires
accurate prediction of the disease course at an early stage. In this study, we evaluated the …

Membranous nephropathy (MN) is a common cause of nephrotic syndrome after
transplantation and is associated with an increased risk of allograft loss. MN may occur …